Related Experiment Video
Updated: Jul 19, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Clinicians' attitudes to prostate cancer peer-support groups.
Suzanne K Steginga1, David P Smith, Carole Pinnock
1Community Services, Queensland Cancer Fund, PO Box 201, Spring Hill QLD 4004, Australia. suzannesteginga@qldcancer.com.au
Most clinicians view prostate cancer peer support groups positively but rarely refer patients. Concerns about misinformation and patient regret hinder referrals, highlighting a need for dialogue to improve support services.
Area of Science:
- Oncology
- Patient Support Services
- Healthcare Professional Education
Background:
- Prostate cancer peer support groups are crucial for enhancing patient care.
- Clinicians' attitudes towards these groups significantly influence patient engagement and experience.
- Understanding clinician perspectives is key to optimizing support networks for prostate cancer patients.
Purpose of the Study:
- To evaluate healthcare providers' knowledge and attitudes regarding prostate cancer peer support initiatives.
- To identify barriers and facilitators influencing clinician referrals to peer support programs.
- To inform strategies for improving the integration of peer support into prostate cancer care.
Main Methods:
- In-depth interviews with 36 Australian clinicians (urologists and radiation oncologists).
- Key-informant approach utilized for qualitative data collection.
- Survey validation with 30 clinicians to confirm thematic findings.
Main Results:
- Majority of clinicians possess fair to good knowledge of peer support groups and rate them positively.
- Less than 25% of clinicians regularly refer patients to available peer support resources.
- Clinicians express concerns regarding potential misinformation and patient decisional regret stemming from peer support interactions.
Conclusions:
- Clinician concerns about misinformation in peer support groups act as a barrier to patient referrals.
- Further research is required to identify specific patient populations who benefit most from peer support.
- Establishing dialogue between prostate cancer advocacy groups and clinicians is essential for addressing concerns and enhancing support services.
More Related Videos
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Related Concept Videos
Self-Help Support Groups
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
Group Therapy
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Healthcare Agencies I
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Prevention
Some...